RPCONE
MRNA icon

Retirement Planning Company of New England’s Moderna MRNA Stock Holding History

Retirement Planning Company of New England’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-210
Closed -$53K – 632
2021
Q4 		$53K Buy
+210
New +$61.4K 0.03% 394

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Retirement Planning Company of New England's MRNA Position: Q1 2022 in Review

Retirement Planning Company of New England sold out of Moderna (MRNA) in Q1 2022, closing a stake of 210 shares — an estimated $53K sold.

Retirement Planning Company of New England first reported a position in MRNA in Q4 2021 and held it in 1 quarter. The position peaked at $53K in Q4 2021. 1,007 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.

  • Retirement Planning Company of New England reported no remaining Moderna position as of Q1 2022 after selling out during the quarter.
  • Retirement Planning Company of New England sold 210 Moderna shares in Q1 2022, an estimated $53K.
  • Retirement Planning Company of New England first reported a position in Moderna in Q4 2021 and held it in 1 quarter.
  • Retirement Planning Company of New England's Moderna position peaked at $53K in Q4 2021.
  • 1,007 funds tracked by Wall St. Rank held Moderna as of Q1 2022.

Based on Retirement Planning Company of New England's 13F filing for Q1 2022, filed 6 May 2022.